Can a special toothbrush stop pneumonia in ICU patients?
NCT ID NCT07125495
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether using a suction toothbrush for oral care could reduce ventilator-associated pneumonia (VAP) in intubated ICU patients. 111 adults on breathing machines were randomly assigned to cleaning with distilled water or a chlorhexidine solution using the suction toothbrush. The goal was to see if this approach lowers infection risk by removing secretions better than standard care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- suction toothbrush
- What this could lead to
- If effective, this simple oral care tool could lower pneumonia risk for patients on breathing machines in ICUs.
- What could go wrong
- This is a small, completed trial with no phase designation. Results may not apply to all ICU settings or patient groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
111 people
The number who actually took part.
- Started
-
Feb 2025
- Finished
-
Sep 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Patients * who aged over 18 years * who underwent orotracheal intubation after admission to the ICU, * who had no known pneumonia or diagnosis of pneumonia at the time of intubation, * who were intubated for more than 48 hours, * who had no microorganisms detected in the tracheal aspirate within the first 48 hours, * who had no lesions on the oral mucous membrane before intubation, * who had no known allergy to chlorhexidine were included in the study. Exclusion Criteria: Patients * who under 18 years of age, * those with a tracheostomy, * those were intubated for less than 48 hours, * those with microorganisms detected in their tracheal aspirate within the first 48 hours, * those who underwent reintubation, * those were pregnant, * those with lesions in the oral mucosa during intensive care admission, * those with bleeding coagulation disorders or thrombocytopenia, * those admitted to intensive care from an external institution while intubated, and those with a known chlorhexidine allergy were excluded from the study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Infection are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Koç University hospital Intensive care unit
Istanbul, 34010, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a handheld device match standard monitors for measuring exhaled CO2?
- Can a simple blood test predict sepsis two days early?
- Switching stomach drugs after transplant may tame a deadly immune attack
- Can a common steroid tame severe flu in the ICU?
- Can telemedicine bring IV antibiotics home?
- Blood test may forecast recovery in elderly infection patients